A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

NCT07544862 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chengdu Kangnuoxing Biopharma,Inc.